This report on the uses of nucleic acid amplification (NAA) tests for diagnosis of TB is based on contributions of an expert panel of consultants convened by the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL). The report presents the...
This report presents the Centers for Disease Control and Prevention's (CDC) updated recommendations on the use of nucleic acid amplification tests (NAA) for TB diagnosis. These revised guidelines were developed on the basis of a report by a panel of clinicians, laboratorians, and TB control...
This report discusses a client-centered approach to treating latent tuberculosis infection (LTBI) in substance abusers at an outpatient treatment facility. The report describes needs assessment at a specific clinic, including the client profile, initial medical screening, existing TB follow-up...
In a question and answer format, this information sheet discusses testing for tuberculosis (TB). There are two kinds of tests that are used to determine if a person has been infected with TB bacteria: the tuberculin skin test (TST) and TB blood tests. It explains these two kinds of tests in detail...
This information sheet discusses interferon-gamma release assays (IGRAs), which are whole-blood tests used in diagnosing both latent TB infection and TB disease. It notes that two IGRAs have been approved by the US Food and Drug Administration (FDA) and are commercially available in the United...
This information sheet discusses infection control measures for health care settings to ensure prompt detection, take airborne precautions, and treat persons with suspected or diagnosed tuberculosis infection. It suggests that policies and procedures for TB control should be developed, reviewed...
This report reviews the new CDC guidelines about TB screening for immigrants and the medical treatment of infected persons. Recent immigration trends and the epidemiology of TB among immigrants is examined. The report discusses the prioritization of TB case finding, screening, and preventive therapy...
This book describes the technical framework and principles used to implement DOTS-Plus in resource poor settings. It also provides a number of case histories that illustrate common challenges in the treatment of MDR TB patients. The book includes protocols that can be used under DOTS-Plus program...
This booklet explains the action and resources needed over the next five years for six working groups to expand, adapt, and improve DOTS, enabling the working groups to meet the 2005 global targets of setting the world on the road to the elimination of TB.
